Literature DB >> 18618132

Limiting factors in peak oxygen uptake and the relationship with functional ambulation in ambulating children with spina bifida.

J F De Groot1, T Takken, M A G C Schoenmakers, L Vanhees, P J M Helders.   

Abstract

The objective of this study is to interpret the outcomes of peak oxygen uptake (VO(2peak)) in children with SB and explore the relationship between VO(2peak) and functional ambulation using retrospective cross-sectional study. Twenty-three ambulating children with SB participated at Wilhelmina's Children's Hospital Utrecht, the Netherlands. VO(2peak) was measured during a graded treadmill-test. Eschenbacher's and Maninna's algorithm was used to determine limiting factors in reaching low VO(2peak) values. Energy expenditure during locomotion (both O(2) rate and O(2) cost) and percentage of VO(2peak) and HR(peak) were determined during a 6-min walking test (6MWT). Differences between community and normal ambulators were analyzed. VO(2peak), VO(2peak)/kg, HR(peak), RER(peak) and VE (peak) were significantly lower compared to reference values, with significant differences between normal and community ambulators. Limiting factors according to the algorithm were mostly "muscular and/or deconditioning" (47%) and ventilatory "gasexchange" (35%). Distance walked during 6MWT was 48.5% of predicted distance. Both O(2) rate and O(2) cost were high with significant differences between normal and community ambulators [17.6 vs. 21.9 ml/(kg min) and 0.27 vs 0.43 ml/(kg m)]. Also %HR(peak) and %VO(2peak) were significantly higher in community ambulators when compared to normal ambulators (resp. 97.6 vs. 75% and 90.2 vs. 55.9%). VO(2peak) seems to be mostly limited by deconditioning and/or muscular components and possible ventilatory factors. For both peak values and functional ambulation, community ambulators were significantly more impaired than normal ambulators. High energy expenditure, %VO(2peak) and %HR(peak) reflect high level of strain during ambulation in the community ambulators. Future exercise testing in children with SB should include assessment of ventilatory reserve. Exercise training in ambulatory children should focus on increasing both VO(2peak) and muscular endurance, as well as decreasing energy cost of locomotion.

Entities:  

Mesh:

Year:  2008        PMID: 18618132     DOI: 10.1007/s00421-008-0820-9

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  49 in total

1.  Validity of body mass index compared with other body-composition screening indexes for the assessment of body fatness in children and adolescents.

Authors:  Zuguo Mei; Laurence M Grummer-Strawn; Angelo Pietrobelli; Ailsa Goulding; Michael I Goran; William H Dietz
Journal:  Am J Clin Nutr       Date:  2002-06       Impact factor: 7.045

2.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

3.  Validation of the portable VmaxST system for oxygen-uptake measurement.

Authors:  M-A Brehm; J Harlaar; H Groepenhof
Journal:  Gait Posture       Date:  2004-08       Impact factor: 2.840

4.  Pulmonary dysfunction and reduced exercise capacity in patients with myelomeningocele.

Authors:  M S Sherman; J M Kaplan; S Effgen; D Campbell; F Dold
Journal:  J Pediatr       Date:  1997-09       Impact factor: 4.406

5.  Heart rate and walking velocity during independent walking in children with low and midlumbar myelomeningocele.

Authors:  Asa Bartonek; M Eriksson; H Saraste
Journal:  Pediatr Phys Ther       Date:  2002       Impact factor: 3.049

6.  Reference values for maximum work capacity in relation to body composition in healthy Dutch children.

Authors:  V A Gulmans; K de Meer; R A Binkhorst; P J Helders; W H Saris
Journal:  Eur Respir J       Date:  1997-01       Impact factor: 16.671

7.  Determinants of functional independence and quality of life in children with spina bifida.

Authors:  M A G C Schoenmakers; C S P M Uiterwaal; V A M Gulmans; R H J M Gooskens; P J M Helders
Journal:  Clin Rehabil       Date:  2005-09       Impact factor: 3.477

8.  Six-minute walk test in children and adolescents.

Authors:  Ralf Geiger; Alexander Strasak; Benedikt Treml; Klaus Gasser; Axel Kleinsasser; Victoria Fischer; Harald Geiger; Alexander Loeckinger; Joerg I Stein
Journal:  J Pediatr       Date:  2007-04       Impact factor: 4.406

9.  Kinetics of compensatory gait in persons with myelomeningocele.

Authors:  Elena M Gutierrez; Asa Bartonek; Yvonne Haglund-Akerlind; Helena Saraste
Journal:  Gait Posture       Date:  2005-01       Impact factor: 2.840

10.  Abnormalities in control of ventilation in newborn infants with myelomeningocele.

Authors:  M C Petersen; M Wolraich; A Sherbondy; J Wagener
Journal:  J Pediatr       Date:  1995-06       Impact factor: 4.406

View more
  5 in total

Review 1.  Metabolic Syndrome in Children With Myelomeningocele and the Role of Physical Activity: A Narrative Review of the Literature.

Authors:  Gabrielle Gour-Provençal; Camille Costa
Journal:  Top Spinal Cord Inj Rehabil       Date:  2022-08-17

2.  Cardiopulmonary exercise testing in congenital heart disease: (contra)indications and interpretation.

Authors:  T Takken; A C Blank; E H Hulzebos; M van Brussel; W G Groen; P J Helders
Journal:  Neth Heart J       Date:  2009-10       Impact factor: 2.380

3.  A review of the potential for cardiometabolic dysfunction in youth with spina bifida and the role for physical activity and structured exercise.

Authors:  Kevin R Short; Dominic Frimberger
Journal:  Int J Pediatr       Date:  2012-06-14

4.  Wheelchair Shuttle Test for Assessing Aerobic Fitness in Youth With Spina Bifida: Validity and Reliability.

Authors:  Manon A T Bloemen; Janke F de Groot; Frank J G Backx; Joyce Benner; Cas L J J Kruitwagen; Tim Takken
Journal:  Phys Ther       Date:  2017-10-01

5.  Decreased respiratory performance of children and adolescents with myelomeningocele who use a wheelchair - preliminary data.

Authors:  E J Martins; A C Gastaldi; G B Q Davoli; M M Leonardi-Figueiredo; A C Mattiello-Sverzut
Journal:  Braz J Med Biol Res       Date:  2019-08-05       Impact factor: 2.590

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.